Human
Research Protection Program
The Human Research Protection Program (HRPP) at Brookhaven National Laboratory (BNL)
encompasses all research involving human subjects performed at or in
conjunction with BNL. Human subjects research includes a wide variety of
activities such as in vivo and in vitro studies, research on medical
records, collection of data through surveys or observation, research using
pathological specimens, discarded tissue, secretions and genetic material
and use of investigational drugs or devices.
The Standards Based Management System (SBMS) for Human Subjects Research is a step by
step guide for Principal Investigators conducting
research with human subjects. Instructions for submitting protocols are detailed on the SBMS and the applications forms are
found below and through IRBNet. Policies and procedures for the HRPP can be found in
the HRPP Manual. Policies and
procedures for the Clinical Research Center can be found in the
CRC Policies and
Procedures Manual.
The Institutional Official (IO) for Human Subjects Research
is the Signatory Official legally authorized to represent
BNL to assure protections for human subjects as specified in the
FederalWide
Assurance (.doc) between Brookhaven Science Associates, LLC (BSA) and
the Department of Health and Human Services (DHHS).
The Office of Research Administration (ORA) provides administrative support
for the BNL Human Subjects Research Program and reports directly to the IO.
The Institutional Review Board (IRB) for BNL is the State University
at Stony Brook (SB) Committee on Research Involving Humans Subjects
(CORIHS).
Prior to submission to CORIHS, all protocols must be reviewed and approved
by the
Life Sciences Quality Assurance Committee. Once a protocol has been approved, the
Clinical Research
Center Quality Assurance Committee
ensures the safety of human subjects as they participate in research
protocols at BNL by evaluating the environment of care provided for research
subjects, the safety and security of the research environment, the quality,
content and completeness of the subject record entries and the level of
subject satisfaction.
All experimental radioactive
drugs used in human subjects research must meet the standards established by the
Food and Drug Administration as authorized by
21 CFR Part 361.1. The BNL Radioactive Drug Research Committee (RDRC) is responsible for such compliance.
All submissions are processed through the ORA.
All licensed medical professionals working with human subjects at BNL must be credentialed by the
Credentialing Committee. Forms and instructions are available on the
Credentialing Committee website.
All personnel listed on a human subjects protocol must take, at a minimum,
CITI and HIPAA training. Links to these training courses are available
at
BNL Training.
Complete the Personnel Addition Form to add personnel to a protocol.
Human
Subjects Research at Stony Brook
The function of the CORIHS is to assure that risks
to research subjects are minimized and that risks are reasonable in relation
to the anticipated benefits and to protect the rights and welfare of research
subjects in accordance with the following:
-
Department of Health and Human Services Policy for the Protection of Human
Subjects 45
CFR 46
-
Food and Drug Administration Policy for the Protection of Human Subjects
21 CFR 50
-
Food and Drug Administration Policy for the Protection of Human Subjects
21 CFR 56
-
Department of Energy Protection of Human Subjects 10CFR745
-
Department of Energy Order on the Protection of Human Subjects
O443.1B
-
The Belmont
Report
Please review the the
CORIHS Policies and Procedures.
All CORIHS forms are available and processed through
IRBNet. Please follow the submission directions available through
this link.
All subject personally identifiable information must be maintained in
according to DOE guidance.
FORMS
The following forms may be downloaded by clicking on the document.
Always download the form since they are updated often.
Above are the only official versions of the submission forms.
Always check and use the most current version of the form for submission.
Please use the Points to Consider
and the Investigator
Checklist to ensure all required steps are completed prior to submission
to the ORA.
| ORA Submission Date |
CORIHS
Submission Date |
CORIHS Meeting Date |
| 01/07/13 |
01/21/13 |
02/14/13A |
| 01/28/13 |
02/11/13 |
02/28/13B |
| 02/11/13 |
02/25/13 |
03/14/13A |
| 02/28/13 |
03/11/13 |
03/28/13B |
| 03/11/13 |
03/25/13 |
04/11/13A |
| 03/25/13 |
04/08/13 |
04/25/13B |
| 04/08/13 |
04/22/13 |
05/09/13A |
| 04/22/13 |
05/06/13 |
05/23/13B |
| 05/06/13 |
05/20/13 |
06/13/13A |
| 05/27/13 |
06/10/13 |
06/27/13B |
Research Participant Information
Click here if you are interested in participating in a
research study or just want to learn more about this research.
Related Information

Contact Information
Darcy Mallon
Phone: (631) 344-3362
Fax: (631) 344-3220
Email: mallon@bnl.gov
Address:
Brookhaven National Laboratory
Building 490
PO Box 5000
Upton, NY 11973-5000
Attn: Darcy Mallon

Last Modified: January 3, 2013 Please forward all questions about this site to:
Darcy Mallon
|